Properties
- Form
- tableti
- Dosage mg
- 50
- Pack
- 10
What is it?
Composition: Active substance: diclofenac; 1 tablet contains diclofenac potassium 25 mg or 50 mg; Excipients: tablet core - colloidal anhydrous silica, calcium phosphate, magnesium stearate, corn starch, povidone, sodium starch glycolate (type A); tablet coating - microcrystalline cellulose, red iron oxide (E 172), titanium dioxide (E 171), povidone, polyethylene glycol 8000, sucrose, talc. Pharmaceutical form. Sugar-coated tablets. Pharmacotherapeutic group. Non-steroidal anti-inflammatory and anti-rheumatic agents. Acetic acid derivatives and related substances. ATC code M01A B05. Clinical characteristics. Indications. Voltaren® Rapid 25 mg and 50 mg Short-term treatment (maximum 2 weeks) of acute conditions such as: • Post-traumatic pain, inflammation and swelling, e.g., due to sprains; • Postoperative pain, inflammation and swelling, e.g., after dental or orthopedic surgery; • Pain and/or inflammation accompanying inflammatory gynecological diseases, e.g., primary dysmenorrhea or adnexitis; • Pain syndromes from the spine; • Rheumatic diseases of extra-articular tissues; • As an adjunct in infections of the ENT organs, e.g., pharyngotonsillitis, otitis, accompanied by pronounced pain and inflammation. Voltaren® Rapid 50 mg for adult patients • Migraine attacks with or without aura. In accordance with generally accepted approaches to the treatment of infectious-inflammatory diseases, etiotropic agents should also be used. Isolated elevation of temperature is not an indication for the use of Voltaren® Rapid. Contraindications. • Hypersensitivity to the active substance or any other component of the preparation. • History of allergic reactions in the form of bronchospasm, urticaria, acute rhinitis, nasal polyps or allergy-like symptoms after taking acetylsalicylic acid or other non-steroidal anti-inflammatory drugs. • Gastric ulcer and/or duodenal ulcers, gastrointestinal bleeding or perforation. • Inflammatory diseases of the gastrointestinal tract (Crohn's disease or ulcerative colitis). • Hepatic insufficiency (Child-Pugh class C, liver cirrhosis and ascites). • Renal insufficiency (creatinine clearance <30 ml/min.). • Severe heart failure (NYHA class III-IV). • Therapy of postoperative pain after cardiac surgery. • Last trimester of pregnancy. Method of administration and dosage. Tablets should be swallowed whole, without chewing, with water, preferably before meals. It is recommended to select the dose individually. Side effects can be minimized by using the lowest effective dose for the shortest possible period necessary to control symptoms. For children aged 14 years and above, the daily dose is 50-100 mg, which should be divided into 2-3 doses. The maximum daily dose of 150 mg should not be exceeded. There is currently no data on the use of Voltaren® Rapid for the treatment of migraine attacks in children under 18 years of age. For adults, the recommended dose of the preparation is 100-150 mg per day. In cases of moderate symptom severity, a dose of 75-100 mg per day is usually sufficient. The daily dose should be divided into 2-3 doses. For primary dysmenorrhea, the daily dose of Voltaren® Rapid should be selected individually. The daily dose is usually 50-100 mg. If necessary, the dose can be increased up to a maximum of 200 mg per day for several subsequent menstrual cycles. The use of Voltaren® Rapid tablets should be started at the onset of the first symptoms and continued for several days depending on the response and symptomatology. Migraine. The preparation should be used at the first signs of an attack
